Click for best price
Growth Hormone Deficiency Therapy Market Size, Share 2022
Growth hormone deficiency?(GHD) is a medical condition due to not enough?growth hormone?(GH). ... Some cases are associated with a lack of other pituitary?hormones, in which case it is known as combined pituitary?hormone deficiency. Diagnosis involves blood tests to measure?growth hormone?levels.
This report contains market size and forecasts of Growth Hormone Deficiency Therapy in Global, including the following market information:
Global Growth Hormone Deficiency Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Growth Hormone Deficiency Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Parenteral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Growth Hormone Deficiency Therapy include Eli Lilly, Pfizer, AbbVie, Novo Nordisk, Merck KGaA, Mylan, Bayer, Teva and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Growth Hormone Deficiency Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Growth Hormone Deficiency Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Growth Hormone Deficiency Therapy Market Segment Percentages, by Type, 2021 (%)
Parenteral
Transdermal
Oral
Others
Global Growth Hormone Deficiency Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Growth Hormone Deficiency Therapy Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drugstores
Others
Global Growth Hormone Deficiency Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Growth Hormone Deficiency Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Growth Hormone Deficiency Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Growth Hormone Deficiency Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
| Report Attributes |
Report Details |
| Report Title |
Growth Hormone Deficiency Therapy Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
103 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Growth Hormone Deficiency Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Growth Hormone Deficiency Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Growth Hormone Deficiency Therapy Overall Market Size
2.1 Global Growth Hormone Deficiency Therapy Market Size: 2021 VS 2028
2.2 Global Growth Hormone Deficiency Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Growth Hormone Deficiency Therapy Players in Global Market
3.2 Top Global Growth Hormone Deficiency Therapy Companies Ranked by Revenue
3.3 Global Growth Hormone Deficiency Therapy Revenue by Companies
3.4 Top 3 and Top 5 Growth Hormone Deficiency Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Growth Hormone Deficiency Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Growth Hormone Deficiency Therapy Players in Global Market
3.6.1 List of Global Tier 1 Growth Hormone Deficiency Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Growth Hormone Deficiency Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Growth Hormone Deficiency Therapy Market Size Markets, 2021 & 2028
4.1.2 Parenteral
4.1.3 Transdermal
4.1.4 Oral
4.1.5 Others
4.2 By Type - Global Growth Hormone Deficiency Therapy Revenue & Forecasts
4.2.1 By Type - Global Growth Hormone Deficiency Therapy Revenue, 2017-2022
4.2.2 By Type - Global Growth Hormone Deficiency Therapy Revenue, 2023-2028
4.2.3 By Type - Global Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Growth Hormone Deficiency Therapy Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Global Growth Hormone Deficiency Therapy Revenue & Forecasts
5.2.1 By Application - Global Growth Hormone Deficiency Therapy Revenue, 2017-2022
5.2.2 By Application - Global Growth Hormone Deficiency Therapy Revenue, 2023-2028
5.2.3 By Application - Global Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Growth Hormone Deficiency Therapy Market Size, 2021 & 2028
6.2 By Region - Global Growth Hormone Deficiency Therapy Revenue & Forecasts
6.2.1 By Region - Global Growth Hormone Deficiency Therapy Revenue, 2017-2022
6.2.2 By Region - Global Growth Hormone Deficiency Therapy Revenue, 2023-2028
6.2.3 By Region - Global Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Growth Hormone Deficiency Therapy Revenue, 2017-2028
6.3.2 US Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.3.3 Canada Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.3.4 Mexico Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Growth Hormone Deficiency Therapy Revenue, 2017-2028
6.4.2 Germany Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.4.3 France Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.4.4 U.K. Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.4.5 Italy Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.4.6 Russia Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.4.8 Benelux Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Growth Hormone Deficiency Therapy Revenue, 2017-2028
6.5.2 China Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.5.3 Japan Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.5.4 South Korea Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.5.6 India Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Growth Hormone Deficiency Therapy Revenue, 2017-2028
6.6.2 Brazil Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.6.3 Argentina Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Growth Hormone Deficiency Therapy Revenue, 2017-2028
6.7.2 Turkey Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.7.3 Israel Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Growth Hormone Deficiency Therapy Market Size, 2017-2028
6.7.5 UAE Growth Hormone Deficiency Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Growth Hormone Deficiency Therapy Major Product Offerings
7.1.4 Eli Lilly Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.1.5 Eli Lilly Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Growth Hormone Deficiency Therapy Major Product Offerings
7.2.4 Pfizer Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Growth Hormone Deficiency Therapy Major Product Offerings
7.3.4 AbbVie Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.3.5 AbbVie Key News
7.4 Novo Nordisk
7.4.1 Novo Nordisk Corporate Summary
7.4.2 Novo Nordisk Business Overview
7.4.3 Novo Nordisk Growth Hormone Deficiency Therapy Major Product Offerings
7.4.4 Novo Nordisk Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.4.5 Novo Nordisk Key News
7.5 Merck KGaA
7.5.1 Merck KGaA Corporate Summary
7.5.2 Merck KGaA Business Overview
7.5.3 Merck KGaA Growth Hormone Deficiency Therapy Major Product Offerings
7.5.4 Merck KGaA Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.5.5 Merck KGaA Key News
7.6 Mylan
7.6.1 Mylan Corporate Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Growth Hormone Deficiency Therapy Major Product Offerings
7.6.4 Mylan Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.6.5 Mylan Key News
7.7 Bayer
7.7.1 Bayer Corporate Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Growth Hormone Deficiency Therapy Major Product Offerings
7.7.4 Bayer Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.7.5 Bayer Key News
7.8 Teva
7.8.1 Teva Corporate Summary
7.8.2 Teva Business Overview
7.8.3 Teva Growth Hormone Deficiency Therapy Major Product Offerings
7.8.4 Teva Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.8.5 Teva Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Growth Hormone Deficiency Therapy Major Product Offerings
7.9.4 Novartis Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.9.5 Novartis Key News
7.10 Abbott
7.10.1 Abbott Corporate Summary
7.10.2 Abbott Business Overview
7.10.3 Abbott Growth Hormone Deficiency Therapy Major Product Offerings
7.10.4 Abbott Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.10.5 Abbott Key News
7.11 Roche
7.11.1 Roche Corporate Summary
7.11.2 Roche Business Overview
7.11.3 Roche Growth Hormone Deficiency Therapy Major Product Offerings
7.11.4 Roche Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.11.5 Roche Key News
7.12 Endo International
7.12.1 Endo International Corporate Summary
7.12.2 Endo International Business Overview
7.12.3 Endo International Growth Hormone Deficiency Therapy Major Product Offerings
7.12.4 Endo International Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.12.5 Endo International Key News
7.13 Ipsen
7.13.1 Ipsen Corporate Summary
7.13.2 Ipsen Business Overview
7.13.3 Ipsen Growth Hormone Deficiency Therapy Major Product Offerings
7.13.4 Ipsen Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.13.5 Ipsen Key News
7.14 ANI Pharmaceuticals
7.14.1 ANI Pharmaceuticals Corporate Summary
7.14.2 ANI Pharmaceuticals Business Overview
7.14.3 ANI Pharmaceuticals Growth Hormone Deficiency Therapy Major Product Offerings
7.14.4 ANI Pharmaceuticals Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.14.5 ANI Pharmaceuticals Key News
7.15 TherapeuticsMD
7.15.1 TherapeuticsMD Corporate Summary
7.15.2 TherapeuticsMD Business Overview
7.15.3 TherapeuticsMD Growth Hormone Deficiency Therapy Major Product Offerings
7.15.4 TherapeuticsMD Growth Hormone Deficiency Therapy Revenue in Global Market (2017-2022)
7.15.5 TherapeuticsMD Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Growth Hormone Deficiency Therapy Market Opportunities & Trends in Global Market
Table 2. Growth Hormone Deficiency Therapy Market Drivers in Global Market
Table 3. Growth Hormone Deficiency Therapy Market Restraints in Global Market
Table 4. Key Players of Growth Hormone Deficiency Therapy in Global Market
Table 5. Top Growth Hormone Deficiency Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Growth Hormone Deficiency Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Growth Hormone Deficiency Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Growth Hormone Deficiency Therapy Product Type
Table 9. List of Global Tier 1 Growth Hormone Deficiency Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Growth Hormone Deficiency Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Growth Hormone Deficiency Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Growth Hormone Deficiency Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Growth Hormone Deficiency Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Growth Hormone Deficiency Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Growth Hormone Deficiency Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Growth Hormone Deficiency Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Growth Hormone Deficiency Therapy Product Offerings
Table 32. Eli Lilly Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Growth Hormone Deficiency Therapy Product Offerings
Table 35. Pfizer Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 36. AbbVie Corporate Summary
Table 37. AbbVie Growth Hormone Deficiency Therapy Product Offerings
Table 38. AbbVie Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Novo Nordisk Corporate Summary
Table 40. Novo Nordisk Growth Hormone Deficiency Therapy Product Offerings
Table 41. Novo Nordisk Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Merck KGaA Corporate Summary
Table 43. Merck KGaA Growth Hormone Deficiency Therapy Product Offerings
Table 44. Merck KGaA Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Mylan Corporate Summary
Table 46. Mylan Growth Hormone Deficiency Therapy Product Offerings
Table 47. Mylan Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Bayer Corporate Summary
Table 49. Bayer Growth Hormone Deficiency Therapy Product Offerings
Table 50. Bayer Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Teva Corporate Summary
Table 52. Teva Growth Hormone Deficiency Therapy Product Offerings
Table 53. Teva Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Novartis Corporate Summary
Table 55. Novartis Growth Hormone Deficiency Therapy Product Offerings
Table 56. Novartis Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Abbott Corporate Summary
Table 58. Abbott Growth Hormone Deficiency Therapy Product Offerings
Table 59. Abbott Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Roche Corporate Summary
Table 61. Roche Growth Hormone Deficiency Therapy Product Offerings
Table 62. Roche Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Endo International Corporate Summary
Table 64. Endo International Growth Hormone Deficiency Therapy Product Offerings
Table 65. Endo International Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 66. Ipsen Corporate Summary
Table 67. Ipsen Growth Hormone Deficiency Therapy Product Offerings
Table 68. Ipsen Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 69. ANI Pharmaceuticals Corporate Summary
Table 70. ANI Pharmaceuticals Growth Hormone Deficiency Therapy Product Offerings
Table 71. ANI Pharmaceuticals Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
Table 72. TherapeuticsMD Corporate Summary
Table 73. TherapeuticsMD Growth Hormone Deficiency Therapy Product Offerings
Table 74. TherapeuticsMD Growth Hormone Deficiency Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Growth Hormone Deficiency Therapy Segment by Type in 2021
Figure 2. Growth Hormone Deficiency Therapy Segment by Application in 2021
Figure 3. Global Growth Hormone Deficiency Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Growth Hormone Deficiency Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Growth Hormone Deficiency Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Growth Hormone Deficiency Therapy Revenue in 2021
Figure 8. By Type - Global Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
Figure 12. US Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
Figure 24. China Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Growth Hormone Deficiency Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Growth Hormone Deficiency Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AbbVie Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novo Nordisk Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck KGaA Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mylan Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bayer Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novartis Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Abbott Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Roche Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Endo International Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Ipsen Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. ANI Pharmaceuticals Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. TherapeuticsMD Growth Hormone Deficiency Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
